Dexcom chief commercial officer to retire [Yahoo! Finance]
DexCom, Inc. (DXCM)
Last dexcom, inc. earnings: 4/28 04:03 pm
Check Earnings Report
US:NASDAQ Investor Relations:
dexcom.com/investors
Company Research
Source: Yahoo! Finance
By the numbers Q3 revenue: $994.2 million 2% increase year over year Net income: $134.6 million 11.5% increase year over year Dexcom Chief Commercial Officer Teri Lawver will leave the company as it grapples with challenges following a sales restructuring. Lawver joined the company in January 2023 for the newly created position, after working for Johnson & Johnson for two decades. Lawver will retire at the end of the year and continue as a special adviser to Dexcom through early 2025. CEO Kevin Sayer will lead the commercial organization while the company searches for a permanent replacement. “Teri is a great leader who's advanced our commercial organization in several areas in the past few years,” Sayer told investors on Thursday, listing the launches of the company's G7 continuous glucose monitor and more recently its over-the-counter device, Stelo. “Having managed this team before, I can speak to their quality and look forward to leading them again.” Dexcom has fac
Show less
Read more
Impact Snapshot
Event Time:
DXCM
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
DXCM alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
DXCM alerts
High impacting DexCom, Inc. news events
Weekly update
A roundup of the hottest topics
DXCM
News
- Healthy Returns: Eli Lilly's cholesterol pill impresses in mid-stage trial [CNBC]CNBC
- Medtronic (MDT) Q2 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Oura Ring Major Update To Integrate Key Feature: Blood Sugar Monitoring [Forbes]Forbes
- Dexcom invests $75m in OURA to forge partnership [Yahoo! Finance]Yahoo! Finance
- Oura CEO on new partnership with Dexcom [CNBC]CNBC
DXCM
Earnings
- 10/24/24 - Miss
DXCM
Sec Filings
- 11/18/24 - Form 4
- 11/15/24 - Form 144
- 10/24/24 - Form 10-Q
- DXCM's page on the SEC website